Nevan 0.1% (Ophthalmic Suspension)

5 ml drop: ৳ 150.00

Medicine Details

Category Details
Generic Nepafenac
Company Aristopharma ltd
Also available as
Nevan ts 03 suspension

Product Title

  • Nevan 0.1% Sterile Ophthalmic Suspension
  • Nevan 0.3% Sterile Ophthalmic Suspension

Categories

  • Ophthalmic Medication
  • Nonsteroidal Anti-Inflammatory Drug (NSAID)
  • Post-operative Ocular Pain Treatment
  • Cataract Surgery Medication

Description

  • Treats post-operative ocular pain and inflammation
  • Inhibits surgery induced miosis
  • Prevents post-operative cystoid macular edema (CME)
  • Pharmacologically converts to Amfenac, a potent NSAID
  • Available in 0.1% and 0.3% formulations
  • Contraindicated in patients with hypersensitivity to ingredients or other NSAIDs
  • Reported side effects include foreign body sensation, ocular discomfort, and ocular hyperemia
  • Caution in patients with bleeding tendencies or receiving medications affecting bleeding time

Dosage and Administration

  • Instill 1 drop 3 times daily for 0.1% suspension prior to cataract surgery
  • Instill 1 drop 3 times daily for 0.1% suspension for surgery induced miosis
  • Instill 1 drop 3 times daily for 0.1% suspension for prevention of post-operative CME
  • Instill 1 drop once daily for 0.3% suspension prior to cataract surgery, with additional drop 30 to 120 minutes before surgery

Mode of Action

  • Penetrates the cornea and is converted to Amfenac by ocular tissue hydrolase
  • Inhibits action of cyclooxygenase enzyme required for prostaglandin synthesis

Contraindications

  • Hypersensitivity to any of the ingredients or other NSAIDs

Side Effects

  • Foreign body sensation
  • Lid margin crusting
  • Ocular discomfort
  • Ocular hyperemia

Pregnancy and Lactation

  • Use during pregnancy only if potential benefit justifies potential risk to fetus
  • Use in lactation cautionary due to unknown excretion in human milk

Precautions

  • Caution in patients with known bleeding tendencies or receiving medications affecting bleeding time

Pediatric Uses

  • Safety and effectiveness not established in pediatric patients below 18 years of age

Elderly Patients

  • No overall differences in safety or effectiveness observed between elderly and younger patients

Therapeutic Class

  • Ophthalmic Non-Steroid Drugs

Related Brands